Validation of our MS-MLPA results by Ms-SNuPE analysis, an alternative method to specifically assess methylation of a single CpG dinucleotide, confirmed the presence of MGMT methylation (at position −459 relative to the transcription start site), in 92% of carcinomas. This evidence concerns the gene MGMT and carcinoma.